34081-17-9

Basic information

• Product Name: L-TYROSINE ETHYL ESTER HYDROCHLORIDE
• Synonyms: L-TYROSINE ETHYL ESTER HCL;L-TYROSINE ETHYL ESTER HYDROCHLORIDE SALT;L-TYROSINE ETHYL ESTER MONOHYDROCHLORIDE;L-TRYOSINE ETHYL ESTER HYDROCHLORIDE;ETHYL 2-AMINO-3-(4-HYDROXYPHENYL)PROPANOATE HYDROCHLORIDE;H-TYR-OET HCL;TEE;(S)-2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONIC ACID ETHYL ESTER HCL
• CAS NO: 34081-17-9
• Molecular Formula: C₁₁H₁₅NO₃
• Molecular Weight: 245.7
• EINECS: 223-820-2
• Product Categories: Amino Acid Derivatives
• Mol File: 34081-17-9.mol
• Article Data: 4

Chemical Properties

• Melting Point: 166-170 °C
• Boiling Point: 343.3°Cat760mmHg
• Flash Point: 161.4°C
• Appearance: /
• Density: 1.177g/cm³
• Vapor Pressure: 3.59E-05mmHg at 25°C
• Storage Temp.: −20°C
• CAS DataBase Reference: L-TYROSINE ETHYL ESTER HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: L-TYROSINE ETHYL ESTER HYDROCHLORIDE(34081-17-9)
• EPA Substance Registry System: L-TYROSINE ETHYL ESTER HYDROCHLORIDE(34081-17-9)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 2
• RTECS: YP2580000
• Hazardous Substances Data: 34081-17-9(Hazardous Substances Data)

Usage

General Description

L-TYROSINE ETHYL ESTER HYDROCHLORIDE is a chemical compound that is derived from the amino acid tyrosine. It is a form of tyrosine that has been esterified with ethyl alcohol, resulting in improved solubility and stability. L-TYROSINE ETHYL ESTER HYDROCHLORIDE is commonly used as a supplement to support cognitive function, mood improvement, and stress reduction. It is believed to increase the production of neurotransmitters in the brain, such as dopamine and norepinephrine, which are important for regulating mood and stress levels. L-TYROSINE ETHYL ESTER HYDROCHLORIDE is also used in the field of organic chemistry as a reagent for various chemical reactions. Overall, this compound has diverse applications and potential benefits for both neurological and chemical processes.

InChI:InChI=1/C11H15NO3/c1-2-15-11(14)10(12)7-8-3-5-9(13)6-4-8/h3-6,10,13H,2,7,12H2,1H3/p+1/t10-/m0/s1

Upstream product

• 5619-08-9 tyrosine ethyl ester hydrochloride 
• 64-17-5 ethanol 
• 556-02-5 ?Tyr 

Downstream Products

• 88494-56-8 N-trifluoroacetyl-DL-tyrosine ethyl ester 
• 60-18-4 L-tyrosine 
• 38453-21-3 N-pivaloyltyrosine ethyl ester 
• 556-02-5 ?Tyr 
• 142847-18-5 N-(tert-butoxycarbonyl)tyrosine 
• 123611-96-1 Cu((HOC₆H₄CH₂CH(COOC₂H₅)NC(CH₃))2C₅H₃N)⁽¹⁺⁾*BF₄^(1-) = {Cu(C₃₁H₃₅N₃O₆)}BF₄ 
• 91860-46-7 N,O-bis<(pentafluorophenyl)sulfonyl>tyrosine ethyl ester 
• 2901-77-1 N-acetyltyrosine 
• 23234-44-8 D-tyrosine ethyl ester 
• 101469-25-4 tyrosinamide 
• 36065-22-2 tyrosine hydrazide 
• 949-67-7 L-tyrosine ethyl ester 
• 63293-21-0 N-nicotinoyl-DL-tyrosin-ethyl ester 

Relevant articles and documents

SYNTHESIS OF TYROSINE DERIVED DIPHENOL MONOMERS

A method for preparing diphenol compounds includes adding a hydroxyphenyl carboxylic acid, a tyrosine ethyl ester, hydroxybenzotriazole hydrate and a solvent and stirring to produce a first solution, EDCI HCI is added to the first solution to produce a fi

4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations

Type-2 diabetes (T2D) is a complex metabolic disease characterized by insulin resistance in the liver and peripheral tissues accompanied by a deficiency in pancreatic β-cells. Since their discovery, three subtypes of peroxisome proliferator activated receptors have been identified, namely PPARα, PPARγ and PPARβ/(δ). In this study, we were interested in designing novel PPARγ selective agonists and/or dual PPARα/γ agonists. Based on the typical topology of synthetic PPAR agonists, we focused our design approach on using 4,4-dimethyl-1,2,3,4-tetrahydroquinoline as a novel cyclic scaffold with oxime and acidic head group structural variations.